Dianthus Therapeutics (DNTH) Receivables (2022 - 2026)
Dianthus Therapeutics' Receivables came in at $102,000 for Q4 2025, down 93.7% from $1.61 million a year earlier and down 98.0% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Receivables (2022 - 2026) Analysis & Trends
Going back to Q4 2022, Dianthus Therapeutics' Receivables data covers 11 quarters.
- Receivables carries a three-year compound annual growth rate of -73.7% (FY2022 to FY2025).
- Going back by year, Receivables was $1.61 million in FY2024 (+100.9%), $800,000 in FY2023 (-85.8%) and $5.64 million in FY2022.
- The Q4 2025 figure represents the lowest quarterly Receivables in data going back to Q4 2022.
- Year-over-year, Receivables increased in four of the last six quarters, with growth averaging 73.6%.
- Business Quant data shows DNTH's Receivables at $5.1 million (Q3 2025), $139,000 (Q2 2025) and $1.3 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Dianthus Therapeutics | 5.00 Bn | 4.95 Bn | - | 782,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 782,000.00 |
| Jun 30, 2026 | 306,000.00 |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 751,000.00 |
| Dec 31, 2022 | 5.60 Mn |
API Access
Dianthus Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();